Shares of #Laurus Labs Ltd. are down 15% on Monday, January 27, giving up all the gains it had made during Friday's trading session, when the company had reported its December quarter results.

The stock is down following news reports that the US ordered a pause in foreign aid, which will cause a stoppage of funding for the President's Emergency Plan for AIDS Relief, or PEPFAR, as early as Monday. The move could also interrupt the provision of anti-viral medications (ARVs) for millions.

The PEPFAR program began under the George W. Bush administration and is credited with saving millions of lives all over the world, by providing billions in funding to organisations to combat HIV and also provides ARVs to more than 20 million people across 55 countries, as per the report.